dosing
Articles tagged with “dosing”
How to Track Symptoms Between Low-Dose Ketamine Treatments
Learn how to track symptoms between low-dose ketamine treatments using validated scales, daily logs, and tips for sharing data with your prescriber.
How Far Apart Should Low-Dose Ketamine Treatments Be Spaced?
Low-dose ketamine spacing depends on treatment phase: 2-3x weekly during induction, then every 2-4 weeks for maintenance. See what the evidence supports.
Ketamine Dosage Guide: Ranges, Forms, and How Doses Are Set
How ketamine dosage is set: typical ranges by form (IV, IM, intranasal, oral), what influences your dose, and why protocols are individualized. Patient educa...
Ketamine Troche Dosage: A Patient Reference Guide
Typical sublingual ketamine troche dosage ranges, how lozenges are dosed for depression and maintenance, what to know about increments, and key safety considerations.
PHQ-9 and GAD-7 in Ketamine Dose Adjustment: A Patient Guide
Learn how PHQ-9 and GAD-7 assessments guide ketamine dose adjustments. Patient-focused guide to understanding symptom tracking and dosing decisions.
When to Switch or Stay: NMDA Therapy Discontinuation Rates
New analysis reveals why patients stop NMDA receptor antagonist therapy—and what discontinuation data means for low-dose ketamine monitoring and dosing decisions.
What Dropout Rates Reveal About NMDA Therapy Tolerability
New psychiatric guidance examines why patients stop NMDA antagonist therapy and what side effect data means for low-dose ketamine treatment decisions.
When Ketamine Side Effects Signal Time to Adjust Dose
New clinical analysis examines why patients stop NMDA antagonist therapy—and how smarter dose management may improve remission outcomes in TRD.
Faster TRD Remission Hinges on Measurement and Dose Timing
New analysis in Psychiatric Times shows that symptom tracking and rapid dose adjustment drive faster remission in TRD—here's what it means for ketamine care.
What Side Effect Data Tells Us About Ketamine Dosing
New analysis of NMDA receptor antagonist side effects in treatment-resistant depression underscores why dose optimization and early monitoring matter.
NMDA Antagonist Side Effects: What the Data Says
New clinical analysis examines why patients stop ketamine and esketamine treatment—and what smarter monitoring can do to keep them on track.
Ketamine Side Effects & When to Switch: New Clinical Guidance
New clinical guidance urges tracking PHQ-9 scores, monitoring side effects closely, and switching NMDA treatments sooner to reach remission faster.
Microdosing Ketamine Protocols: Sub-Therapeutic Dose Approaches
What does ketamine microdosing involve? Review of dose ranges, clinical applications, safety considerations, and how it differs from standard low-dose care.
Ketamine Dosing and Administration: A Complete Clinical Guide
Reference guide to ketamine dosage across IV, oral, sublingual troche, and intranasal routes — weight-based dosing, titration, and route-specific protocols.
How Many Ketamine Treatments Are Needed?
Learn why six IV ketamine treatments over 2-3 weeks is a common starting course for depression, how maintenance spacing works, and what to track at follow-up.
What Is the Standard Ketamine Dose for Depression?
What is the standard ketamine dose for depression? 0.5 mg/kg IV over 40 minutes, plus how oral and sublingual low-dose protocols translate from that baseline.
Ketamine Tolerance: Understanding Dose Adjustments Over Time
Do patients build tolerance to ketamine? A clinical review of tolerance mechanisms, clinical signs, and evidence on adjusting dose over repeated treatment.
Pediatric Low-Dose Ketamine: Dosing Considerations and Safety
Pediatric low-dose ketamine dosing considerations and safety, including age-related differences, evidence limits, monitoring, consent, and questions for families.
Esketamine vs Racemic Ketamine Dosing: Comparative Pharmacology
Compare esketamine and racemic ketamine dosing by route, formulation, monitoring, treatment schedule, and the questions to ask a clinician.
Weight-Based Dosing Guidelines for Low-Dose Ketamine
Understand the 0.5 mg/kg IV ketamine research reference, why routes differ, and what to ask about weight-based dosing and follow-up.
Renal and Hepatic Dose Adjustments for Low-Dose Ketamine
Learn how liver and kidney impairment can affect low-dose ketamine planning, monitoring, recovery, and questions to ask a prescribing clinician.
Defining Sub-Anesthetic Ketamine: Dose Ranges and Therapeutic Windows
Sub-anesthetic ketamine spans 0.1 to 1.0 mg/kg depending on indication. Learn how dose, NMDA receptor occupancy, and route shape each therapeutic window.
Dose-Response Relationships in Low-Dose Ketamine Therapy
Learn why low dose ketamine therapy does not have one universal dose, how route and treatment goals affect response, and which questions to bring to follow-up.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.